Tang J, Davis N, Corbett A, Chinula L, Cottrell M, Zia Y
Contracept X. 2020; 2:100027.
PMID: 33364598
PMC: 7752709.
DOI: 10.1016/j.conx.2020.100027.
Natavio M, Stanczyk F, Molins E, Nelson A, Jusko W
Contraception. 2019; 99(5):306-311.
PMID: 30703352
PMC: 6499670.
DOI: 10.1016/j.contraception.2019.01.003.
Thurman A, Schwartz J, Brache V, Clark M, McCormick T, Chandra N
PLoS One. 2018; 13(6):e0199778.
PMID: 29953547
PMC: 6023238.
DOI: 10.1371/journal.pone.0199778.
Nwaohiri A, Tang J, Stanczyk F, Chinula L, Hurst S, Davis N
Contraception. 2017; 97(4):354-356.
PMID: 29246819
PMC: 5840008.
DOI: 10.1016/j.contraception.2017.12.007.
Sciaranghella G, Wang C, Hu H, Anastos K, Merhi Z, Nowicki M
J Infect Dis. 2015; 212(9):1397-401.
PMID: 25895986
PMC: 4601918.
DOI: 10.1093/infdis/jiv233.
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
Edelman A, Cherala G, Munar M, Dubois B, McInnis M, Stanczyk F
Contraception. 2012; 87(2):220-6.
PMID: 23153898
PMC: 3925642.
DOI: 10.1016/j.contraception.2012.10.008.
Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.
Stuart G, Moses A, Corbett A, Phiri G, Kumwenda W, Mkandawire N
J Acquir Immune Defic Syndr. 2011; 58(2):e40-3.
PMID: 21921726
PMC: 3176587.
DOI: 10.1097/QAI.0b013e31822b8bf8.
Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding.
Davis A, Westhoff C, Stanczyk F
Epilepsia. 2011; 52(2):243-7.
PMID: 21204827
PMC: 3057928.
DOI: 10.1111/j.1528-1167.2010.02917.x.
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.
Westhoff C, Torgal A, Mayeda E, Pike M, Stanczyk F
Contraception. 2010; 81(6):474-80.
PMID: 20472113
PMC: 3522459.
DOI: 10.1016/j.contraception.2010.01.016.
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.
Edelman A, Carlson N, Cherala G, Munar M, Stouffer R, Cameron J
Contraception. 2009; 80(2):119-27.
PMID: 19631786
PMC: 2736633.
DOI: 10.1016/j.contraception.2009.04.011.
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.
Sitruk-Ware R, Brache V, Maguire R, Croxatto H, Kumar N, Kumar S
Contraception. 2007; 75(6):454-60.
PMID: 17519152
PMC: 1995403.
DOI: 10.1016/j.contraception.2007.02.003.
Levonorgestrel. Clinical pharmacokinetics.
FOTHERBY K
Clin Pharmacokinet. 1995; 28(3):203-15.
PMID: 7758251
DOI: 10.2165/00003088-199528030-00003.
Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
Gardner M, Tornatore K, Jusko W, Kanarkowski R
Br J Clin Pharmacol. 1983; 16(3):271-80.
PMID: 6626419
PMC: 1427996.
DOI: 10.1111/j.1365-2125.1983.tb02161.x.
Pharmacokinetics of levonorgestrel in Indian women.
Nair K, Sivakumar B, Prema K, NARASINGA RAO B
Eur J Clin Pharmacol. 1983; 24(2):255-9.
PMID: 6404637
DOI: 10.1007/BF00613828.
Clinical pharmacokinetics of oral contraceptive steroids.
Orme M, Back D, Breckenridge A
Clin Pharmacokinet. 1983; 8(2):95-136.
PMID: 6342899
DOI: 10.2165/00003088-198308020-00001.
